649550-98-1 Usage
Uses
Used in Organic Synthesis:
2,2,2-Trifluoro-1-(6-fluoro-1H-indol-3-yl)ethanone is used as a key intermediate in organic synthesis for the creation of complex organic molecules. Its fluorinated ketone structure provides unique reactivity and selectivity in chemical reactions, facilitating the synthesis of novel compounds with tailored properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,2,2-trifluoro-1-(6-fluoro-1H-indol-3-yl)ethanone is utilized as a building block for the development of new drugs. Its fluoro-indole group and fluorinated ketone moiety can be incorporated into drug candidates to enhance their pharmacokinetic and pharmacodynamic profiles, potentially leading to improved therapeutic efficacy and selectivity.
Used in Materials Science:
2,2,2-Trifluoro-1-(6-fluoro-1H-indol-3-yl)ethanone is employed in materials science for the design and synthesis of advanced materials with specific chemical and physical properties. Its unique molecular structure can contribute to the development of materials with applications in various fields, such as electronics, coatings, and sensors.
Overall, the diverse applications of 2,2,2-trifluoro-1-(6-fluoro-1H-indol-3-yl)ethanone across different industries highlight its versatility and potential impact on the development of innovative products and technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 649550-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,9,5,5 and 0 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 649550-98:
(8*6)+(7*4)+(6*9)+(5*5)+(4*5)+(3*0)+(2*9)+(1*8)=201
201 % 10 = 1
So 649550-98-1 is a valid CAS Registry Number.
649550-98-1Relevant academic research and scientific papers
Pyridazinone compound, preparation method thereof, pharmaceutical composition and its use
-
Paragraph 0190-0192, (2018/04/02)
The present invention is in the scope of the field of pharmaceutical chemistry. Specifically, the present invention relates to pyridazinone compounds of formula (I) or isomers, pharmaceutically acceptable salts, esters, prodrugs or solvates thereof, preparation method, pharmaceutical compositions thereof and use in manufacture of tyrosine kinase inhibitors, specially c-Met inhibitors. Said compounds or pharmaceutical compositions are used to prevent and/or treat tumor diseases related to c-Met abnormality as tyrosine kinase inhibitors, specially c-Met inhibitors.
AROMATIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS
-
Paragraph 00416, (2015/07/07)
Provided herein are novel aromatic heterocyclic compounds or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and their uses for treating Alzheimer's disease. Also provided herein are pharmaceutical compositions containing such compounds, and methods for using such compounds or pharmaceutical compositions thereof to treat Alzheimer's disease.
Indole-3-carboxamides as glucokinase activators
-
Page 10, (2010/02/06)
The present invention provides glucokinase activators of formula I: wherein R1, R2 and R3 are defined in the specification. Glucokinase activators are useful for increasing insulin secretion in the treatment of type II diabetes.
